Media coverage about CryoPort (NASDAQ:CYRX) has trended positive on Friday, according to Alpha One Sentiment Analysis. The research firm, a service of Accern, scores the sentiment of news coverage by analyzing more than twenty million blog and news sources. Alpha One ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. CryoPort earned a news sentiment score of 0.37 on Alpha One’s scale. Alpha One also gave news headlines about the company an impact score of 0 out of 100, meaning that recent news coverage is extremely unlikely to have an impact on the company’s share price in the near future.
CYRX has been the subject of a number of research reports. Needham & Company LLC initiated coverage on shares of CryoPort in a research note on Monday, April 3rd. They issued a “buy” rating and a $3.50 price objective for the company. ValuEngine raised shares of CryoPort from a “sell” rating to a “hold” rating in a research note on Thursday, May 11th. Finally, Cowen and Company initiated coverage on shares of CryoPort in a research note on Friday. They issued an “outperform” rating and a $5.50 price objective for the company.
CryoPort (NASDAQ:CYRX) traded up 0.21% during mid-day trading on Friday, reaching $4.68. 309,540 shares of the company were exchanged. CryoPort has a 1-year low of $1.50 and a 1-year high of $4.75. The stock’s 50-day moving average price is $3.35 and its 200-day moving average price is $3.12. The stock’s market capitalization is $112.20 million.
CryoPort (NASDAQ:CYRX) last announced its earnings results on Thursday, May 4th. The company reported ($0.10) EPS for the quarter, beating analysts’ consensus estimates of ($0.14) by $0.04. CryoPort had a negative return on equity of 104.79% and a negative net margin of 137.99%. The company had revenue of $2.71 million during the quarter, compared to analysts’ expectations of $2.59 million. On average, equities research analysts anticipate that CryoPort will post ($0.72) EPS for the current fiscal year.
COPYRIGHT VIOLATION WARNING: This news story was first posted by sleekmoney and is the sole property of of sleekmoney. If you are viewing this news story on another domain, it was illegally stolen and reposted in violation of US and international copyright and trademark legislation. The correct version of this news story can be accessed at https://sleekmoney.com/cryoport-cyrx-receiving-favorable-press-coverage-alphaone-reports/1916767.html.
Cryoport, Inc (Cryoport) is a provider of cryogenic logistics solutions to the life sciences industry through its purpose-built packaging, information technology and specialized cold chain logistics expertise. The Company provides logistics solutions for biologic materials, such as immunotherapies, stem cells, chimeric antigen receptors (CAR)-T cells, and reproductive cells for clients.
This story was originally published by sleekmoney (https://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at https://sleekmoney.com/cryoport-cyrx-receiving-favorable-press-coverage-alphaone-reports/1916767.html
Receive News & Ratings for CryoPort Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CryoPort Inc. and related companies with MarketBeat.com's FREE daily email newsletter.